Does TRANYLCYPROMINE Cause Dysmorphism? 17 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Dysmorphism have been filed in association with TRANYLCYPROMINE (Tranylcypromine). This represents 4.4% of all adverse event reports for TRANYLCYPROMINE.
17
Reports of Dysmorphism with TRANYLCYPROMINE
4.4%
of all TRANYLCYPROMINE reports
9
Deaths
4
Hospitalizations
How Dangerous Is Dysmorphism From TRANYLCYPROMINE?
Of the 17 reports, 9 (52.9%) resulted in death, 4 (23.5%) required hospitalization.
Is Dysmorphism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANYLCYPROMINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does TRANYLCYPROMINE Cause?
Hypertensive crisis (53)
Contraindicated product administered (50)
Drug interaction (44)
Depression (41)
Hypertension (39)
Headache (33)
Drug ineffective (30)
Insomnia (30)
Serotonin syndrome (30)
Dizziness (27)
What Other Drugs Cause Dysmorphism?
VALPROATE (552)
LAMOTRIGINE (134)
VALPROIC ACID (128)
LEVETIRACETAM (113)
CARBAMAZEPINE (85)
CLOBAZAM (54)
TOPIRAMATE (54)
DIVALPROEX (53)
ONDANSETRON (52)
QUETIAPINE (49)
Which TRANYLCYPROMINE Alternatives Have Lower Dysmorphism Risk?
TRANYLCYPROMINE vs TRASTUZUMAB
TRANYLCYPROMINE vs TRASTUZUMAB-ANNS
TRANYLCYPROMINE vs TRASTUZUMAB DERUXTECAN
TRANYLCYPROMINE vs TRASTUZUMAB-DKST
TRANYLCYPROMINE vs TRASTUZUMAB-DTTB